Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NANOFH.HEthis companyNanoform Finland Oyj	€0.77	-5.57×	2.33×	28.12×	-4.3×	-239.2%	-419.8%	-627.6%	-504.7%	-41.8%	-45.3%	-18.7%	0.15×	0.93×	-99.79×	4.31×	0.0%	2	-1.22	2	C
BIOBV.HEBiohit Oyj	€2.13	20.5×	3.76×	3.57×	14.64×	359.3%	38.9%	20.4%	17.4%	18.4%	18.3%	-2.3%	0.11×	-0.52×	32×	2.53×	0.0%	2	6.72	4	A
HRTIS.HEHerantis Pharma Oyj	€1.19	-7.29×	-28.58×	0×	-7.96×	-110.7%	0.0%	0.0%	0.0%	392.4%	-363.1%	-12.6%	-2.04×	-0.42×	-465.23×	2.93×	0.0%	1	-31.84	2	C
MODU.HEModulight Oyj	€1.13	-10.18×	1.05×	6.63×	-1,000.64×	-307.1%	-18.4%	-65.8%	-65.1%	-10.3%	-9.8%	-12.9%	0.06×	171.55×	-21.72×	4.46×	0.0%	5	7.81	2	C+
NXTMH.HENexstim Plc	€8.93	177.5×	24.33×	9.28×	60.62×	-217.5%	35.2%	5.7%	5.2%	13.7%	7.1%	-0.0%	0.99×	0.85×	3.47×	1.25×	0.0%	6	1.85	2	C
OPTOMED.HEOptomed Oyj	€1.76	-11.09×	3.11×	4.37×	-19.12×	-233.3%	-2.2%	-35.4%	-38.8%	-27.6%	-22.2%	-6.5%	0.11×	2.04×	-4.81×	2.39×	0.0%	4	0.9	2	C
Peer median	—	-7.29×	3.11×	4.37×	-7.96×	-217.5%	0.0%	0.0%	0.0%	13.7%	-9.8%	-6.5%	0.11×	0.85×	-4.81×	2.53×	0.0%	4	1.85	2	—